Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.00029 | 1 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0002 | 1 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.00021 | 1 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.00015 | 1 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.00018 | 1 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.00013 | 1 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 6.2e-05 | 1 |